BridgeMD
New treatment option for Intraventricular Hemorrhage
Official title Lumbar Drainage of Intraventricular Hemorrhage
ClinicalTrials.gov ID: NCT06510842
What this study is testing
- What it's testing
- Intracerebral hemorrhage (ICH) is a debilitating and fatal disease, especially when the hemorrhage is also entering the cerebral ventricles leading to acute hydrocephalus. In these cases, patients need a drainage through external ventricular drains (EVD).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ICH with IVH (with hemorrhage in the 3rd and/or 4rth ventricle) with the need for EVD placement due to acute hydrocephalus
- Age ≥ 18 y
- Lumbar drain can be inserted within 72 h after symptom onset or patient last seen well
You likely can't join if
- Premorbid mRS score \> 2
- Pregnancy
- Life expectancy \<6 months
- Patient/family/caregiver unwilling or unlikely to opt for at least two weeks of aggressive therapy prior to consideration of transition to comfort...
- Treating physicians deeming the prognosis as so grave that an aggressive therapy is not warranted.
- Other clear contraindication for treatment with a lumbar drain
The study team makes the final eligibility decision.
Where it's taking place
- Heidelberg, Baden-Wurttemberg, Germany
- München, Bavaria, Germany
- Augsburg, Germany
- Berlin, Germany
- Düsseldorf, Germany
- Frankfurt, Germany
- Göttingen, Germany
- Heidelberg, Germany
- Mainz, Germany
- Mannheim, Germany
- Osnabrück, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Heidelberg, Baden-Wurttemberg, Germany; München, Bavaria, Germany; Augsburg, Germany; Berlin, Germany; Düsseldorf, Germany; Frankfurt, Germany and 5 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.